Dolby Laboratories, Inc. (DLB)
NYSE: DLB · Real-Time Price · USD
62.10
+0.33 (0.53%)
At close: Aug 10, 2026, 4:00 PM EDT
61.56
-0.54 (-0.87%)
Pre-market: Aug 11, 2026, 7:13 AM EDT
Dolby Laboratories Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 26, 2026 | Sep '25 Sep 26, 2025 | Sep '24 Sep 27, 2024 | Sep '23 Sep 29, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 24, 2021 |
| 1,354 | 1,349 | 1,274 | 1,300 | 1,254 | 1,281 | |
Revenue Growth | 0.55% | 5.92% | -2.00% | 3.67% | -2.14% | 10.28% |
Cost of Revenue | 167.78 | 160.13 | 140.5 | 152.57 | 141.36 | 130.03 |
Gross Profit | 1,187 | 1,189 | 1,133 | 1,147 | 1,112 | 1,151 |
Selling, General & Admin | 658.8 | 647.24 | 604.85 | 612.84 | 634.03 | 556.83 |
Research & Development | 265.94 | 261.79 | 263.66 | 271.52 | 261.17 | 253.64 |
Other Operating Expenses | 22.73 | 15.01 | 6.38 | 47.06 | 10.62 | 10.24 |
Total Operating Expenses | 947.48 | 924.04 | 874.9 | 931.43 | 905.83 | 820.71 |
Operating Income | 239.1 | 264.96 | 258.33 | 215.75 | 206.61 | 344.39 |
Interest Income | 17.66 | 15.38 | 34.08 | 28.09 | 6.17 | 3.01 |
Other Non-Operating Income (Expense) | 20.02 | 23.15 | 20.08 | 6.21 | 2.5 | 7.11 |
Total Non-Operating Income (Expense) | 37.67 | 38.53 | 54.15 | 34.3 | 8.67 | 10.12 |
Pretax Income | 276.77 | 303.49 | 312.48 | 250.05 | 215.28 | 354.51 |
Provision for Income Taxes | 48.77 | 46.99 | 48.16 | 48.41 | 31.38 | 36.69 |
Net Income | 228 | 256.49 | 264.32 | 201.64 | 183.9 | 317.82 |
Minority Interest in Earnings | 1.59 | 1.47 | 2.49 | 0.99 | -0.19 | 7.6 |
Net Income to Common | 226.18 | 255.02 | 261.83 | 200.66 | 184.09 | 310.23 |
Net Income Growth | -14.41% | -2.60% | 30.48% | 9.00% | -40.66% | 34.09% |
Shares Outstanding (Basic) | 95 | 96 | 96 | 96 | 100 | 101 |
Shares Outstanding (Diluted) | 96 | 97 | 97 | 98 | 102 | 105 |
Shares Change | -1.10% | 0.16% | -0.42% | -4.17% | -2.52% | 1.63% |
EPS (Basic) | 2.38 | 2.66 | 2.74 | 2.10 | 1.84 | 3.07 |
EPS (Diluted) | 2.35 | 2.62 | 2.69 | 2.05 | 1.81 | 2.97 |
EPS Growth | -13.92% | -2.60% | 31.22% | 13.26% | -39.06% | 32.00% |
Free Cash Flow | 442.84 | 435.85 | 297.25 | 336.74 | 270.65 | 393.3 |
Free Cash Flow Growth | 1.09% | 46.63% | -11.73% | 24.42% | -31.19% | 41.73% |
Free Cash Flow Per Share | 4.61 | 4.47 | 3.05 | 3.45 | 2.65 | 3.76 |
Dividends Per Share | 1.440 | 1.350 | 1.230 | 1.110 | 1.020 | 0.910 |
Dividend Growth | 9.09% | 9.76% | 10.81% | 8.82% | 12.09% | 3.41% |
Gross Margin | 87.61% | 88.13% | 88.97% | 88.26% | 88.73% | 89.85% |
Operating Margin | 17.65% | 19.64% | 20.28% | 16.60% | 16.48% | 26.88% |
Profit Margin | 16.83% | 19.01% | 20.75% | 15.51% | 14.67% | 24.81% |
FCF Margin | 32.70% | 32.31% | 23.34% | 25.91% | 21.59% | 30.70% |
EBITDA | 356.08 | 352.79 | 333.89 | 298.31 | 295.07 | 440.25 |
EBITDA Margin | 26.29% | 26.15% | 26.21% | 22.95% | 23.53% | 34.36% |
EBIT | 239.1 | 264.96 | 258.33 | 215.75 | 206.61 | 344.39 |
EBIT Margin | 17.65% | 19.64% | 20.28% | 16.60% | 16.48% | 26.88% |
Effective Tax Rate | 17.62% | 15.48% | 15.41% | 19.36% | 14.58% | 10.35% |